Member Info for Roostersmillions

'Rovshan Najaf and Musabbeh Al Kaabi preparing a bid'

Anyone have a link to this? And the barclays £10 estimate.

Saw that, I guess that's the reason for the SP spurt

Good news money,

Maybe that was the purpose of the NASDAQ listing and links to US.

70.47 please

Looks like a few punters are taking their profit at the end of the week. Can't blame them if that's their strategy.

The good news is that the share price is holding up.

Good luck longterm holders, hopefully another good week next week

Does the trimming of staff and contractors make the company more attractive for a buyer???

Less HR and redundancy post buy out, and easier restructuring of the buyers current staff?

Just a thought. Any views?

That's the main takeaway right there Money.

We might have to wait for news sometimes. But that's cos Eric don't BS. When he says that he means it.

Https://www.ajbell.co.uk/articles/latestnews/284085/genflow-biosciences-enters-2025-confidence-research-progress

Nice little piece on the AJ Bell site. Bit of rehash of 6/1 RNS, but good exposure to a potential new set of buyers.

Ha ha, I think setting your sights a little lower will reduce the heartache.

I'm also looking at fund management for the divs mainly, but I do see growth in the sector.

Hopefully ABDN can drag itself back into the FTSE 100.

Pity the LSE can't enforce a couple of hours overtime

You could get out and take your 4%ish profit. Then you won't have yourself to blame in 6 months if it goes wrong.

All good news Porter.

And a good start to the day with 800,000 taken up.

On the money, Money.

The recent big volume buys could be an indicator.

All those big late trades have to be buys as well looking at the price when they went through. Hopefully a good afternoon for holders

Start again, fat fingers posted to early

Anyone seen this company LSE:HEMO.

Cell genetics in a different medical are to Genflow.

It appears they have set up a clinic to start human trials, which should start soon.

On quick glance it appears they aren't funded very long into the future, some posters suggesting that they haven't the cash to finish trials.

The market cap is twice Genf.

Looking at the two, I'm happier with Eric and our team and Genflows progress. But we should be at least the same market cap as HEMO.

Anyone seen this company LSE:HEMO.

Cell genetics in a different medical are to Genflow.

It appears they have set up a clinic to start human trial

Well Money,

The 2p has gone, let's hope it's the last time we see it.

I'm thinking there's legs in this today, on the risers list and today's good news articles could see 2.5p broken.

Good luck to all long term holders

Good to see the ask hit 2p.

A few more buys from these good news articles and the SP will break the 2p and hopefully carry on rising.

Https://www.share-talk.com/rns-hotlist-with-zak-mir-ftc-genf-axl-gmet-herc-geln-plsr-srt-avon/

And already a big riser today, over 13% up per google finance

Not the busiest day today.